Beyond Meat Inc has a consensus price target of $20.1 based on the ratings of 18 analysts. The high is $122 issued by Citigroup on October 25, 2021. The low is $3 issued by Piper Sandler on September 22, 2023. The 3 most-recent analyst ratings were released by Canaccord Genuity, BMO Capital, and Goldman Sachs on May 10, 2024, May 9, 2024, and May 9, 2024, respectively. With an average price target of $6.5 between Canaccord Genuity, BMO Capital, and Goldman Sachs, there's an implied 5.71% upside for Beyond Meat Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/10/2024 | Buy Now | 13.84% | Canaccord Genuity | Bobby Burleson | $9 → $7 | Maintains | Hold | Get Alert |
05/09/2024 | Buy Now | 46.37% | BMO Capital | Andrew Strelzik | $10 → $9 | Maintains | Market Perform | Get Alert |
05/09/2024 | Buy Now | -43.08% | Goldman Sachs | Adam Samuelson | $4 → $3.5 | Maintains | Sell | Get Alert |
04/22/2024 | Buy Now | -2.42% | Mizuho | John Baumgartner | $7 → $6 | Maintains | Underperform | Get Alert |
04/17/2024 | Buy Now | -2.42% | TD Cowen | Robert Moskow | $10 → $6 | Maintains | Sell | Get Alert |
02/29/2024 | Buy Now | — | Argus Research | Kristina Ruggeri | — | Upgrade | Sell → Hold | Get Alert |
02/29/2024 | Buy Now | 13.84% | Mizuho | John Baumgartner | $5 → $7 | Maintains | Underperform | Get Alert |
02/28/2024 | Buy Now | 62.63% | BMO Capital | Andrew Strelzik | $7 → $10 | Maintains | Market Perform | Get Alert |
11/09/2023 | Buy Now | 13.84% | BMO Capital | Andrew Strelzik | $13 → $7 | Maintains | Market Perform | Get Alert |
11/02/2023 | Buy Now | -18.68% | Barclays | Benjamin Theurer | $9 → $5 | Maintains | Underweight | Get Alert |
10/12/2023 | Buy Now | -18.68% | Mizuho | John Baumgartner | → $5 | Downgrade | Neutral → Underperform | Get Alert |
09/22/2023 | Buy Now | -51.21% | Piper Sandler | Michael Lavery | $6 → $3 | Maintains | Underweight | Get Alert |
09/13/2023 | Buy Now | 62.63% | TD Cowen | Robert Moskow | → $10 | Initiates | → Underperform | Get Alert |
08/08/2023 | Buy Now | 111.42% | BMO Capital | Andrew Strelzik | $14 → $13 | Maintains | Market Perform | Get Alert |
06/01/2023 | Buy Now | 46.37% | Barclays | Benjamin Theurer | $10 → $9 | Maintains | Underweight | Get Alert |
05/12/2023 | Buy Now | 95.16% | Mizuho | John Baumgartner | $20 → $12 | Maintains | Neutral | Get Alert |
04/14/2023 | Buy Now | 160.21% | BMO Capital | Andrew Strelzik | → $16 | Reinstates | → Market Perform | Get Alert |
02/27/2023 | Buy Now | 62.63% | Credit Suisse | Robert Moskow | → $10 | Reiterates | → Underperform | Get Alert |
02/24/2023 | Buy Now | 192.74% | Bernstein | Alexia Howard | $10 → $18 | Maintains | Market Perform | Get Alert |
02/24/2023 | Buy Now | 225.26% | Mizuho | John Baumgartner | $11 → $20 | Maintains | Neutral | Get Alert |
12/09/2022 | Buy Now | — | Argus Research | Kristina Ruggeri | — | Downgrade | Hold → Sell | Get Alert |
11/28/2022 | Buy Now | 62.63% | Barclays | Benjamin Theurer | $13 → $10 | Downgrade | Equal-Weight → Underweight | Get Alert |
11/23/2022 | Buy Now | -18.68% | Goldman Sachs | Adam Samuelson | $14 → $5 | Maintains | Sell | Get Alert |
11/10/2022 | Buy Now | 127.68% | BMO Capital | Kenneth Zaslow | $20 → $14 | Maintains | Market Perform | Get Alert |
11/10/2022 | Buy Now | 78.89% | Mizuho | John Baumgartner | $27 → $11 | Maintains | Neutral | Get Alert |
10/17/2022 | Buy Now | 127.68% | Canaccord Genuity | Bobby Burleson | $15 → $14 | Maintains | Hold | Get Alert |
10/17/2022 | Buy Now | 111.42% | Barclays | Benjamin Theurer | $30 → $13 | Maintains | Equal-Weight | Get Alert |
10/17/2022 | Buy Now | -2.42% | Piper Sandler | Michael Lavery | $8 → $6 | Maintains | Underweight | Get Alert |
10/12/2022 | Buy Now | 143.95% | Canaccord Genuity | Bobby Burleson | $22 → $15 | Maintains | Hold | Get Alert |
09/21/2022 | Buy Now | 30.1% | Piper Sandler | Michael Lavery | $9 → $8 | Maintains | Underweight | Get Alert |
08/23/2022 | Buy Now | 46.37% | Piper Sandler | Michael Lavery | $12 → $9 | Maintains | Underweight | Get Alert |
08/08/2022 | Buy Now | 339.1% | Mizuho | John Baumgartner | $21 → $27 | Maintains | Neutral | Get Alert |
08/08/2022 | Buy Now | 387.89% | Barclays | Benjamin Theurer | $25 → $30 | Maintains | Equal-Weight | Get Alert |
08/05/2022 | Buy Now | 387.89% | UBS | Cody Ross | $20 → $30 | Maintains | Neutral | Get Alert |
08/05/2022 | Buy Now | 62.63% | B of A Securities | Peter Galbo | $20 → $10 | Maintains | Underperform | Get Alert |
05/13/2022 | Buy Now | 225.26% | Credit Suisse | Robert Moskow | $40 → $20 | Maintains | Underperform | Get Alert |
05/12/2022 | Buy Now | 322.84% | Cowen & Co. | Brian Holland | $42 → $26 | Maintains | Market Perform | Get Alert |
05/12/2022 | Buy Now | 387.89% | BMO Capital | Kenneth Zaslow | $60 → $30 | Maintains | Market Perform | Get Alert |
05/12/2022 | Buy Now | 241.52% | Mizuho | John Baumgartner | $35 → $21 | Maintains | Neutral | Get Alert |
05/12/2022 | Buy Now | 127.68% | Goldman Sachs | Adam Samuelson | $40 → $14 | Maintains | Sell | Get Alert |
05/12/2022 | Buy Now | 95.16% | Piper Sandler | Michael Lavery | $29 → $12 | Maintains | Underweight | Get Alert |
05/12/2022 | Buy Now | 306.58% | Barclays | Benjamin Theurer | $80 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
05/03/2022 | Buy Now | 469.21% | Mizuho | John Baumgartner | $45 → $35 | Maintains | Neutral | Get Alert |
03/30/2022 | Buy Now | 680.63% | UBS | Cody Ross | → $48 | Initiates | → Neutral | Get Alert |
03/28/2022 | Buy Now | 371.63% | Piper Sandler | Michael Lavery | $50 → $29 | Downgrade | Neutral → Underweight | Get Alert |
03/07/2022 | Buy Now | 550.52% | Goldman Sachs | Adam Samuelson | $47 → $40 | Maintains | Sell | Get Alert |
02/28/2022 | Buy Now | 875.78% | BMO Capital | Kenneth Zaslow | $68 → $60 | Maintains | Market Perform | Get Alert |
02/25/2022 | Buy Now | 713.15% | Canaccord Genuity | Bobby Burleson | $80 → $50 | Maintains | Hold | Get Alert |
02/25/2022 | Buy Now | 420.42% | JP Morgan | Ken Goldman | $54 → $32 | Maintains | Underweight | Get Alert |
02/25/2022 | Buy Now | 713.15% | Piper Sandler | Michael Lavery | $64 → $50 | Maintains | Neutral | Get Alert |
02/25/2022 | Buy Now | 631.84% | Mizuho | John Baumgartner | $59 → $45 | Maintains | Neutral | Get Alert |
02/02/2022 | Buy Now | 1005.89% | BMO Capital | Kenneth Zaslow | → $68 | Initiates | → Market Perform | Get Alert |
01/31/2022 | Buy Now | 1201.05% | Barclays | Benjamin Theurer | $70 → $80 | Upgrade | Underweight → Overweight | Get Alert |
01/27/2022 | Buy Now | 859.52% | Mizuho | John Baumgartner | → $59 | Initiates | → Neutral | Get Alert |
01/21/2022 | Buy Now | — | HSBC | Jeremy Fialko | — | Downgrade | Reduce → Hold | Get Alert |
12/14/2021 | Buy Now | 940.84% | Piper Sandler | Michael Lavery | — | Upgrade | Underweight → Neutral | Get Alert |
11/30/2021 | Buy Now | 908.31% | HSBC | Jeremy Fialko | — | Initiates | → Reduce | Get Alert |
11/11/2021 | Buy Now | 1070.94% | Piper Sandler | Michael Lavery | — | Maintains | Underweight | Get Alert |
11/11/2021 | Buy Now | 875.78% | Credit Suisse | Robert Moskow | — | Maintains | Underperform | Get Alert |
11/11/2021 | Buy Now | 1526.31% | Bernstein | Alexia Howard | — | Downgrade | Outperform → Market Perform | Get Alert |
10/27/2021 | Buy Now | 1526.31% | Canaccord Genuity | Bobby Burleson | — | Maintains | Hold | Get Alert |
10/26/2021 | Buy Now | 1119.73% | Credit Suisse | Robert Moskow | — | Downgrade | Neutral → Underperform | Get Alert |
10/25/2021 | Buy Now | 1884.09% | Citigroup | Wendy Nicholson | — | Maintains | Buy | Get Alert |
10/25/2021 | Buy Now | 1201.05% | Barclays | Benjamin Theurer | — | Maintains | Underweight | Get Alert |
09/16/2021 | Buy Now | 1444.99% | Piper Sandler | Michael Lavery | — | Downgrade | Neutral → Underweight | Get Alert |
09/10/2021 | Buy Now | 1916.62% | Cowen & Co. | Brian Holland | — | Initiates | → Market Perform | Get Alert |
08/25/2021 | Buy Now | — | Argus Research | Jim Kelleher | — | Downgrade | Buy → Hold | Get Alert |
The latest price target for Beyond Meat (NASDAQ:BYND) was reported by Canaccord Genuity on May 10, 2024. The analyst firm set a price target for $7.00 expecting BYND to rise to within 12 months (a possible 13.84% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Beyond Meat (NASDAQ:BYND) was provided by Canaccord Genuity, and Beyond Meat maintained their hold rating.
The last upgrade for Beyond Meat Inc happened on February 29, 2024 when Argus Research raised their price target to N/A. Argus Research previously had a sell for Beyond Meat Inc.
The last downgrade for Beyond Meat Inc happened on October 12, 2023 when Mizuho changed their price target from N/A to $5 for Beyond Meat Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Beyond Meat, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Beyond Meat was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
While ratings are subjective and will change, the latest Beyond Meat (BYND) rating was a maintained with a price target of $9.00 to $7.00. The current price Beyond Meat (BYND) is trading at is $6.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.